PATH Stock Recent News
PATH LATEST HEADLINES
UiPath NYSE: PATH is at the forefront of the enterprise automation software sector, providing powerful tools that enable businesses to automate repetitive tasks, streamline workflows, and boost overall efficiency. However, UiPath's stock price is down close to 50% year to date, which has left many investors wondering if this is a buying opportunity or a sign of further decline.
NEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a leading agentic automation and AI software company, today announced that it will host an Investor Session at FORWARD + TechEd 2024, its annual user conference. The Investor Session will be hosted in person at the MGM Grand in Las Vegas on October 21, 2024, from 4:00 pm to 5:00 pm PT (7:00 pm to 8:00 pm ET). The session will feature members from the executive team, a customer panel, and live Q&A. FORWARD + TechEd will offer inspiration,.
Given the recent plummet in PATH's share price, we evaluate its current position to determine whether investors should buy, hold or sell the stock.
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UiPath is a buy due to its strong recurring revenue, high gross margins, and horizontal product relevance across industries, despite recent sales slowdowns. The company has implemented strategic changes, including leadership shifts, workforce restructuring, and new product launches, to address growth and execution challenges. UiPath's valuation is attractive at
Tom Yeung here, with this week's Sunday Digest. Last week, I wrote how smaller companies tend to outperform when the U.S. Federal Reserve cuts rates.
JAKARTA, Indonesia--(BUSINESS WIRE)--UiPath announced a partnership with Indosat Ooredoo Hutchison to empower 100,000 Indonesians with enterprise automation skills by 2027.
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
UiPath has struggled this year as its growth rate has been slowing down and it's nowhere near posting a profit. The consensus analyst price target for the stock is nearly $18, suggesting a good amount of upside for investors.
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.